Computer-aided detection and radiation therapy firm iCAD has received clearance from the U.S. Food and Drug Administration (FDA) for its new cervical applicator for use with the Xoft Axxent electronic brachytherapy system.
The applicator delivers high-dose-rate brachytherapy for intracavitary treatment of cancer of the uterus, cervix, endometrium, and vagina, according to the firm.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
